Innovative and safe hand sanitizer for healthcare workers to help fight the current SARS-CoV-2 Pandemic.
We are a research & development company focused on completing the clinical studies on an innovative, safe and pertinent hand sanitizer with potential efficacy against viruses like Norovirus and SARS-CoV-2. The current pandemic has emphasized the need for novel solutions to meet the demands of emerging pathogens. In-vitro studies have demonstrated base-ingredient efficacy against difficult to kill pathogens with ingredients that are safe for multiple, daily applications on health workers' hands.
The product would also be available for regions of the world without easy access to water to help prevent the spread of diseases. Funding is required to continue our push forward with current research at independent laboratories to meet FDA requirements (safety and efficacy). It is our goal to get this product approved to help in the current fight against SARS-CoV-2 and other dangerous pathogens.
We are currently struggling to meet our research costs competing against the more widely marketed hand sanitizer companies who are not interested in novel hand sanitizers being introduced at this time. We have references available from our independent research labs, our regulatory team in Washington, D.C., and others as required by donors. The studies have been underway and currently directed by our Chief Science Officer Stephen D. Newman, M.D. and Chief Microbiologist Robert Pond. Current research cannot move forward without additional funding. Please help if you are able. Thank you.
Please check out our video below: